PTC Therapeutics Inc (NASDAQ:PTCT)

31.99
Delayed Data
As of May 18
 +0.45 / +1.43%
Today’s Change
12.15
Today|||52-Week Range
33.22
+91.79%
Year-to-Date
No recent news for PTC Therapeutics Inc.

Today’s Trading

Previous close31.54
Today’s open31.63
Day’s range31.33 - 32.58
Volume966,075
Average volume (3 months)990,908
Market cap$1.4B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+51.56%
Earnings growth (this year)+45.12%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+135.04%
P/E ratioNM
Price/Sales3.36
Price/Book7.83

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc0.000.00%
ADROAduro Biotech Inc-0.15-1.85%
EGRXEagle Pharmaceutical...-3.23-4.71%
ENTAEnanta Pharmaceutica...-1.71-1.61%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$194.4M
Annual profit (last year)-$79.0M
Net profit margin-40.64%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Chief Operating Officer
Marcio Souza
Corporate headquarters
South Plainfield, New Jersey

Forecasts